Zepto Expands Into Home Diagnostics Through Partnership With Orange Health Labs

Zepto has launched at-home diagnostic testing on its platform, enabling users to book full-body checkups, thyroid panels, blood sugar tests, CBCs, and other routine pathology services directly through the app. The service, powered by Orange Health Labs, offers home sample collection within 60 minutes and reports within six hours, with pricing starting at ₹180.

Rapid Diagnostics Strengthen Zepto’s Healthcare Strategy
The move builds on Zepto’s entry into e-pharmacy earlier this year, positioning the company among leading digital health players such as Tata 1mg, PharmEasy, Apollo 24/7, and Amazon. With consumer platforms increasingly shifting toward integrated care, Zepto’s adoption of fast, home-based diagnostics aligns with growing demand for hyperlocal, full-stack healthcare services.

Industry Momentum Toward Full-Stack Digital Health Services
Zepto’s rollout mirrors broader market dynamics, including Amazon India’s diagnostic expansion with Orange Health Labs earlier this year. The company’s push into diagnostics also comes as it prepares to refile IPO documents and targets $450–$500 million in fresh equity, following a recent $450 million fundraise to accelerate operations and expand its healthcare footprint.